(Total Views: 804)
Posted On: 05/29/2023 2:14:29 PM
Post# of 154850
Dr.Scott Hansen's work has led to two research publications (one pending publication) that has alreadt furthered Cytodyn's understanding of the MOA and potential applications of Leronlimab in NASH and Oncology.
He has been mindful of Leronlimab since the spring of 2021.
"Dr. Jonah Sacha a colleaque of mine at OHSU, asked me to help with the receptor occupancy and Biomarker analysis for Leronlimab on a exploratory basis"...
"I was blown away by the data we were generating at the Lab." ...and suggested "this isn't just a Molecule to prevent HIV,... IT is much more than that"__Dr. Scott Hansen PhD,
He has been mindful of Leronlimab since the spring of 2021.
"Dr. Jonah Sacha a colleaque of mine at OHSU, asked me to help with the receptor occupancy and Biomarker analysis for Leronlimab on a exploratory basis"...
"I was blown away by the data we were generating at the Lab." ...and suggested "this isn't just a Molecule to prevent HIV,... IT is much more than that"__Dr. Scott Hansen PhD,
(14)
(0)
